{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:57:51Z","timestamp":1768726671917,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.xphs.2018.10.023","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T02:53:49Z","timestamp":1540522429000},"page":"1211-1219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Chemometric Models for Quantification of Carbamazepine Anhydrous and Dihydrate Forms in the Formulation"],"prefix":"10.1016","volume":"108","author":[{"given":"Sogra F.","family":"Barakh Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyaur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathish","family":"Dharani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamideh","family":"Afrooz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2018.10.023_bib1","series-title":"Tegretol\u00ae label","year":"2018"},{"key":"10.1016\/j.xphs.2018.10.023_bib2","series-title":"Carbatrol\u00ae label","year":"2018"},{"key":"10.1016\/j.xphs.2018.10.023_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejpb.2007.09.003","article-title":"Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique","volume":"69","author":"Tayel","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2018.10.023_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional biopharmaceutical classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2018.10.023_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2006.09.018","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of carbamazepine-loaded enteric microparticles","volume":"331","author":"Dong","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.10.023_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejps.2004.03.010","article-title":"Bioavailability of carbamazepine: \u03b2-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets","volume":"22","author":"Koeste","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2018.10.023_bib8","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/jps.10455","article-title":"Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I","volume":"92","author":"Grzesiak","year":"2003","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.10.023_bib9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1021\/cg201665z","article-title":"Examining solution and solid state composition for the solution-mediated polymorphic transformation of carbamazepine and piracetam","volume":"12","author":"O\u2019Mahony","year":"2012","journal-title":"Cryst Growth Des"},{"issue":"10","key":"10.1016\/j.xphs.2018.10.023_bib10","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1021\/js960117e","article-title":"Characterization of dihydrates prepared from carbamazepine polymorphs","volume":"85","author":"McMahon","year":"1996","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.023_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0731-7085(00)00262-4","article-title":"Solid-state study of polymorphic drugs: carbamazepine","volume":"23","author":"Rustichelli","year":"2000","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.023_bib12","first-page":"28","article-title":"Influence of simulated gastrointestinal fluids on polymorphic behavior of anhydrous carbamazepine form III and biopharmaceutical relevance","volume":"64","author":"Bhise","year":"2010","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2018.10.023_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(99)00315-4","article-title":"Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate","volume":"193","author":"Kobayashi","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.10.023_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1590\/S1984-82502014000400023","article-title":"Thermoanalytical studies of carbamazepine: hydration\/dehydration, thermal decomposition, and solid phase transitions","volume":"50","author":"Pinto","year":"2014","journal-title":"Braz J Pharm Sci"},{"key":"10.1016\/j.xphs.2018.10.023_bib15","series-title":"Towards Better Safety of Drugs and Pharmaceutical Products","first-page":"265","article-title":"The problems of drug interactions with excipients","author":"Stahl","year":"1980"},{"issue":"12","key":"10.1016\/j.xphs.2018.10.023_bib16","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1023\/A:1015872626887","article-title":"The bioinequivalence of carbamazepine tablets with a history of clinical failures","volume":"9","author":"Meyer","year":"1992","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.10.023_bib17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1177\/00912700022009558","article-title":"Who needs individual bioequivalence studies for narrow therapeutic index drugs? A case for warfarin","volume":"40","author":"Yacobi","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.xphs.2018.10.023_bib18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jps.20644","article-title":"Analytical techniques for quantification of amorphous\/crystalline phases in pharmaceutical solids","volume":"95","author":"Shah","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2018.10.023_bib19","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1002\/jps.23712","article-title":"Chemometric evaluation of near infrared, fourier transform infrared, and Raman spectroscopic models for the prediction of nimodipine polymorphs","volume":"102","author":"Siddiqui","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.10.023_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0169-409X(01)00101-6","article-title":"Characterization of the solid-state: spectroscopic techniques","volume":"48","author":"Bugay","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2018.10.023_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejpb.2006.12.002","article-title":"Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy","volume":"66","author":"Tian","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2018.10.023_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpba.2013.01.042","article-title":"Multivariate analysis of quaternary carbamazepine-saccharine mixtures by X-ray diffraction and infrared spectroscopy","volume":"78-79","author":"Caliandro","year":"2013","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"9","key":"10.1016\/j.xphs.2018.10.023_bib23","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.3390\/molecules190914128","article-title":"Simultaneous quantification of three polymorphic forms of carbamazepine in the presence of excipients using Raman spectroscopy","volume":"19","author":"Farias","year":"2014","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.023_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpba.2005.07.030","article-title":"Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy","volume":"40","author":"Tian","year":"2006","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2018.10.023_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1021\/mp050099m","article-title":"Reaction crystallization of pharmaceutical molecular complexes","volume":"3","author":"Rodriguez","year":"2006","journal-title":"Mol Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.10.023_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2018.01.005","article-title":"Quantitative estimation of phenytoin sodium disproportionation in the formulations using vibration spectroscopies and multivariate methodologies","volume":"539","author":"Dharani","year":"2018","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.023_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1208\/s12249-011-9603-4","article-title":"Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide","volume":"12","author":"Rahman","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.xphs.2018.10.023_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/10837450.2010.546412","article-title":"Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin","volume":"17","author":"Rahman","year":"2012","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2018.10.023_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jrs.1134","article-title":"A\u00a0theoretical and spectroscopic study of carbamazepine polymorphs","volume":"35","author":"Strachan","year":"2004","journal-title":"J\u00a0Raman Spectrosc"},{"key":"10.1016\/j.xphs.2018.10.023_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1255\/jnirs.786","article-title":"Incorporating chemical band-assignment in near infrared spectroscopy regression models","volume":"16","author":"Westad","year":"2008","journal-title":"J\u00a0Near Infrared Spec"},{"key":"10.1016\/j.xphs.2018.10.023_bib31","series-title":"A\u00a0User-Friendly Guide to Multivariate Calibration and Classification","first-page":"344","author":"Naes","year":"2002"},{"key":"10.1016\/j.xphs.2018.10.023_bib32","series-title":"Data Preprocessing in Infrared Spectroscopy for Food Quality Analysis and Control","first-page":"29","author":"Rinnan","year":"2009"},{"issue":"8","key":"10.1016\/j.xphs.2018.10.023_bib33","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/jps.24524","article-title":"Chemometric model development and comparison of Raman and (13)C solid-state nuclear magnetic resonance-chemometric methods for quantification of crystalline\/amorphous warfarin sodium fraction in the formulations","volume":"104","author":"Rahman","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2018.10.023_bib34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/ac00162a020","article-title":"Partial least-squares methods for spectral analyses. Relation to other quantitative calibration methods and the extraction of qualitative information","volume":"60","author":"David","year":"1988","journal-title":"Anal Chem"},{"issue":"1-3","key":"10.1016\/j.xphs.2018.10.023_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0169-7439(87)80084-9","article-title":"Principal component analysis","volume":"2","author":"Wold","year":"1987","journal-title":"Chemometr Intell Lab Syst"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918306233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918306233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T11:30:04Z","timestamp":1550057404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918306233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0022354918306233"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.10.023","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemometric Models for Quantification of Carbamazepine Anhydrous and Dihydrate Forms in the Formulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}